Biomaterials and nanomaterials for sustained release vaccine delivery.
Wiley Interdiscip Rev Nanomed Nanobiotechnol
; 13(6): e1735, 2021 11.
Article
in English
| MEDLINE | ID: covidwho-1283762
ABSTRACT
Vaccines are considered one of the most significant medical advancements in human history, as they have prevented hundreds of millions of deaths since their discovery; however, modern travel permits disease spread at unprecedented rates, and vaccine shortcomings like thermal sensitivity and required booster shots have been made evident by the COVID-19 pandemic. Approaches to overcoming these issues appear promising via the integration of vaccine technology with biomaterials, which offer sustained-release properties and preserve proteins, prevent conformational changes, and enable storage at room temperature. Sustained release and thermal stabilization of therapeutic biomacromolecules is an emerging area that integrates material science, chemistry, immunology, nanotechnology, and pathology to investigate different biocompatible materials. Biomaterials, including natural sugar polymers, synthetic polyesters produced from biologically derived monomers, hydrogel blends, protein-polymer blends, and metal-organic frameworks, have emerged as early players in the field. This overview will focus on significant advances of sustained release biomaterial in the context of vaccines against infectious disease and the progress made towards thermally stable "single-shot" formulations. This article is categorized under Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Biocompatible Materials
/
Vaccines
/
Delayed-Action Preparations
/
Nanostructures
Type of study:
Prognostic study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Wiley Interdiscip Rev Nanomed Nanobiotechnol
Year:
2021
Document Type:
Article
Affiliation country:
Wnan.1735
Similar
MEDLINE
...
LILACS
LIS